An E-Box-Mediated Increase in cad Transcription at the G₁/S-Phase Boundary Is Suppressed by Inhibitory c-Myc Mutants

REFERENCES

• Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (London) 359:423–426.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., and R. N. Eisenman. 1993. A switch from Myc:Max to Mad:Max hetercomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7:2110–2119.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211–222.
   PubMed Web of Science ®Google Scholar
• Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317–4324.
   PubMed Web of Science ®Google Scholar
• Beckmann, H., L. Su, and T. Kadesch. 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer mE3 motif. Genes Dev. 4:167–179.
   PubMed Web of Science ®Google Scholar
• Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804–7808.
   PubMed Web of Science ®Google Scholar
• Bendall, A. J., and P. L. Molloy. 1994. Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 22:2801–2810.
   PubMed Web of Science ®Google Scholar
• Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513–2523.
   PubMedGoogle Scholar
• Berberich, S., N. Hyde-DeRuyscher, P. Espenshade, and M. Cole. 1992. max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. Oncogene 7:775–779.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., B. Lüscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71–80.
   PubMed Web of Science ®Google Scholar
• Buermeyer, A. B., N. E. Thompson, L. A. Strasheim, R. R. Burgess, and P. J. Farnham. 1992. The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II. Mol. Cell. Biol. 12:2250–2259.
   PubMedGoogle Scholar
• Carr, C. S., and P. A. Sharp. 1990. A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol. Cell. Biol. 10:4384–4388.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., M. McGuire, M. Buckmire, and W. M. F. Lee. 1989. Involvement of the ‘leucine zipper’ region in the oligomerization and transforming activity of human c-myc protein. Nature (London) 337:664–666.
   PubMed Web of Science ®Google Scholar
• Dean, M., R. A. Levine, W. Ran, M. S. Kindy, G. E. Sonenshein, and J. Campisi. 1986. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J. Biol. Chem. 261:9161–9166.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dou, Q.-P., S. Zhao, A. H. Levin, J. Wang, K. Helin, and A. B. Pardee. 1994. G1/S-regulated E2F-containing protein complexes bind to the mouse thymi-dine kinase gene promoter. J. Biol. Chem. 269:1306–1313.
   PubMedGoogle Scholar
• Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the α-prothymosin gene. EMBO J. 10:133–141.
   PubMed Web of Science ®Google Scholar
• Eisenman, R. N., C. Y. Tachibana, H. D. Abrams, and S. R. Hann. 1985. v-myc and c-myc-encoded proteins are associated with the nuclear matrix. Mol. Cell. Biol. 5:114–126.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44–49.
   PubMed Web of Science ®Google Scholar
• Evans, D. R. 1986. CAD, a chimeric protein that initiates de novo pyrimidine biosynthesis in higher eucaryotes, p. 283–331. In D. G. Hardie, and J. R. Coggins (ed.), Multidomain proteins—structure and evolution. Elsevier Biomedical Press, Amsterdam.
   Google Scholar
• Farnham, P. J., and R. Kollmar. 1990. Characterization of the 59 end of the growth-regulated syrian hamster CAD gene. Cell Growth Differ. 1:179–189.
   PubMedGoogle Scholar
• Farnham, P. J., J. E. Slansky, and R. Kollmar. 1993. The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta 1155:125–131.
   PubMed Web of Science ®Google Scholar
• Gregor, P. D., M. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730–1740.
   PubMed Web of Science ®Google Scholar
• Halazonetis, T. D., and A. N. Kandil. 1991. Determination of the c-MYC DNA-binding site. Proc. Natl. Acad. Sci. USA 88:6162–6166.
   PubMedGoogle Scholar
• Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature (London) 328: 445–449.
   PubMed Web of Science ®Google Scholar
• Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factor E2F-1 and DP1 leads to cooperative trans-activation. Genes Dev. 7:1850–1861.
   PubMed Web of Science ®Google Scholar
• Hsiao, K.-M., S. L. McMahon, and P. J. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526–1537.
   PubMed Web of Science ®Google Scholar
• Hu, Y., B. Lüscher, A. Admon, N. Mermod, and R. Tjian. 1990. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev. 4:1741–1752.
   PubMed Web of Science ®Google Scholar
• Ivey-Hoyle, M., R. Conroy, H. E. Huber, P. J. Goodhart, A. Oliff, and D. C. Heimbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13:7802–7812.
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (London) 365:349–352.
   PubMed Web of Science ®Google Scholar
• Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal domain of c-Myc required for transformation activates transcription. Mol. Cell. Biol. 10:5914–5920.
   PubMed Web of Science ®Google Scholar
• Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Kollmar, R., M. J. Lindstrom, and P. J. Farnham. 1992. Heat sensitivity and Sp1 activation of complex formation at the Syrian hamster carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/di-hydroorotase promoter in vitro. J. Biol. Chem. 267:385–391.
   PubMedGoogle Scholar
• Kollmar, R., K. A. Sukow, S. K. Sponagle, and P. J. Farnham. 1994. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hy-drolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J. Biol. Chem. 269:2252–2257.
   PubMedGoogle Scholar
• Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557–1560.
   PubMed Web of Science ®Google Scholar
• Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature (London) 359:426–429.
   PubMedGoogle Scholar
• Lam, E. W.-F., J. D. H. Morris, R. Davies, T. Crook, R. J. Watson, and K. H. Vousden. 1994. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J. 13:871–878.
   PubMed Web of Science ®Google Scholar
• Lam, E. W.-F., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705–2713.
   PubMed Web of Science ®Google Scholar
• Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596–602.
   PubMed Web of Science ®Google Scholar
• Letovsky, J., and W. S. Dynan. 1989. Measurement of the binding of transcription factor Sp1 to a single GC box recognition sequence. Nucleic Acids Res. 17:2639–2653.
   PubMed Web of Science ®Google Scholar
• Li, L., G. S. Naeve, and A. S. Lee. 1993. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation. Proc. Natl. Acad. Sci. USA 90:3554–3558.
   PubMedGoogle Scholar
• Li, Y., J. E. Slansky, D. J. Myers, N. R. Drinkwater, W. G. Kaelin, and P. J. Farnham. 1994. Cloning, chromosomal location, and characterization of mouse E2F1. Mol. Cell. Biol. 14:1861–1869.
   PubMedGoogle Scholar
• Liao, W. S. L., R. Heller, P. Green, and G. R. Stark. 1986. Regulation of carbamoyl phosphate synthetase-aspartate transcarbamoylase-dihydrooro-tase gene expression in growing and arrested cells. J. Biol. Chem. 261:15577–15581.
   PubMedGoogle Scholar
• Lim, K., and C.-B. Chae. 1989. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosi-dase. BioTechniques 7:576–579.
   PubMed Web of Science ®Google Scholar
• Lüscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb. I. Myc. Genes Dev. 4:2025–2035.
   PubMed Web of Science ®Google Scholar
• Makino, R., K. Hayashi, and T. Sugimura. 1984. c-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature (London) 310:697–698.
   PubMed Web of Science ®Google Scholar
• Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809–860.
   PubMed Web of Science ®Google Scholar
• Means, A. L., J. E. Slansky, S. L. McMahon, M. W. Knuth, and P. J. Farnham. 1992. The HIP1-binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 12:1054–1063.
   PubMedGoogle Scholar
• Miltenberger, R. J. Unpublished data.
   Google Scholar
• Miltenberger, R. J., J. Cortner, and P. J. Farnham. 1993. An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes. J. Biol. Chem. 268:15674–15680.
   PubMedGoogle Scholar
• Mudryj, M., S. W. Hiebert, and J. R. Nevins. 1990. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9:2179–2184.
   PubMedGoogle Scholar
• Mukherjee, B., S. D. Morgenbesser, and R. A. DePinho. 1992. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev. 6:1480–1492.
   PubMedGoogle Scholar
• Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429.
   PubMed Web of Science ®Google Scholar
• Peña, A., C. D. Reddy, S. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and K. J. Soprano. 1993. Regulation of human ornithine decar-boxylase expression by the c-Myc:c-Max protein complex. J. Biol. Chem. 268:27277–27285.
   PubMedGoogle Scholar
• Prendergast, G. C., D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65:395–407.
   PubMed Web of Science ®Google Scholar
• Prochownik, E. V., J. Kukowska, and C. Rodgers. 1988. c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol. Cell. Biol. 8:3683–3695.
   PubMed Web of Science ®Google Scholar
• Rabbitts, P. H., J. V. Watson, A. Lamond, A. Forster, M. A. Stinson, G. Evan, W. Fischer, E. Atherton, R. Sheppard, and T. H. Rabbitts. 1985. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4:2009–2015.
   PubMed Web of Science ®Google Scholar
• Rao, G. N., and R. L. Church. 1988. Regulation of CAD gene expression in mouse fibroblasts during the transition from the resting to the growing state. Exp. Cell Res. 178:449–456.
   PubMedGoogle Scholar
• Reisman, D., N. B. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4:57–65.
   PubMedGoogle Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Singh, P., S. H. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:3329–3338.
   PubMed Web of Science ®Google Scholar
• Slansky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13:1610–1618. (Author's correction, 13:7201.)
   PubMed Web of Science ®Google Scholar
• Solomon, D. L. C., B. Amati, and H. Land. 1993. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res. 21:5372–5376.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B., P. B. Challoner, P. E. Neiman, and M. Groudine. 1985. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (London) 314:363–366.
   PubMed Web of Science ®Google Scholar
• Waters, C. M., T. D. Littlewood, D. C. Hancock, J. P. Moore, and G. I. Evan. 1991. c-myc protein expression in untransformed fibroblasts. Oncogene 6:797–805.
   PubMed Web of Science ®Google Scholar
• Watt, R., L. W. Stanton, K. B. Marcu, R. C. Gallo, C. M. Croce, and G. Rovera. 1983. Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature (London) 303:725–728.
   PubMed Web of Science ®Google Scholar
• Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223–232.
   PubMed Web of Science ®Google Scholar